The ROC curve analysis revealed that the MIR600HG/hsa-miR-342-3p/ANLN-related risk model effectively predicted the 1-year, 3-year, and 5-year survival rates of patients with pancreatic cancer based on TCGA dataset (Fig. 4E). This evidence concerns the gene ANLN and pancreatic neoplasm.